David McIntosh: Do Current Global Blood and Plasma Systems Provide the Care Patients Deserve?
David McIntosh, Founder and Chair of United Plasma Action, shared a post by Global Anemia and Patient Blood Management on LinkedIn:
“Global Blood and Plasma Supplies…..Don’t Patients deserve better?
Parts 1 and 2 of this series outlined the World’s significant under-performance in blood and plasma collection and the fatal consequences for millions of patients, worldwide.
The aspiration here is to stimulate further discussion among practitioners, influencers and decision-makers in the Blood and Plasma fields, in the hope of reaching agreement on new approaches to our global problem, with the shared goals of ensuring that:
- All patients have access to life-saving medicines
so that
- Unnecessary suffering and avoidable mortality are eliminated asap
It is devoutly hoped, dear reader, that future editions will incorporate your feedback and further comments ….. Thank you!”
Find more posts featuring David McIntosh on Hemostasis Today.
-
Jun 3, 2026, 05:16WFH Highlights the Vision for Health Equity in Bleeding Disorders at WHA79
-
Jun 3, 2026, 04:12Lynne Baird: Why Bleed Control Kits Belong in Every Public Space
-
Jun 2, 2026, 19:42Sékouba Sidimé: vWD vs Hemophilia A – The Classic USMLE Step 1 trap in Hematology
-
Jun 2, 2026, 19:41Bassem M. Mohammed: How Factor VIII Interacts To Procoagulant Membranes To Support Activation Of Blood Clotting
-
Jun 2, 2026, 19:28Looking Beyond Bleeding Control To Understand Inflammation In Hemophilic Arthropathy – CRH French Reference Center for Hemophilia Lyon
-
Jun 2, 2026, 19:27Francisco Chacón-Lozsán: Coma Is Not a Diagnosis – Final Pathway Of Brain Arousal And Awareness Failure
-
Jun 2, 2026, 19:26Panagiotis Papanagiotou: Recognizing CVST On T2 MRI
-
Jun 2, 2026, 17:56Coralie Delporte Gravouil: Scientific Program 2026 – Essentials of Hemostasis Now Available
-
Jun 2, 2026, 17:55Anna Rivera: Hemophilia Management – A Shift from Traditional IV Therapies to Novel Subcutaneous Agents